Astin Margaret P, Martins Tanimola, Welton Nicky, Neal Richard D, Rose Peter W, Hamilton William
NIHR Centre for Academic Primary Care, University of Bristol. Bristol.
University of Exeter Medical School, Exeter.
Br J Gen Pract. 2015 Oct;65(639):e677-91. doi: 10.3399/bjgp15X686941.
Selection of primary care patients for investigation of potential oesophagogastric cancer is difficult, as the symptoms may represent benign conditions, which are also more common.
To review systematically the presenting features of oesophagogastric cancers in primary care, including open-access endoscopy clinics.
Systematic review and meta-analysis.
MEDLINE®, Embase, the Cochrane Library, and CINAHL were searched for studies of adults who were symptomatic and presented in primary care or open-access endoscopy clinics. Exclusions were being asymptomatic, screening, or recurrent cancers. Data were extracted to estimate the diagnostic performance of features of oesophagogastric cancers and summarised in a meta-analysis.
Fourteen studies were identified. The strongest summary sensitivity and specificity estimates were for: dyspepsia 0.42 (95% confidence interval [CI] 0.29 to 0.56) and 0.48 (95% CI = 0.31 to 0.65); pain 0.41 (95% CI = 0.24 to 0.62) and 0.75 (95% CI = 0.51 to 0.89); and dysphagia 0.32 (95% CI = 0.17 to 0.52) and 0.92 (95% CI = 0.81 to 0.97). Summary positive likelihood ratios (LR+) and diagnostic odds ratios were: dyspepsia 0.79 (95% CI = 0.55 to 1.15) and 0.65 (95% CI = 0.32 to 1.33); pain 1.64 (95% CI = 1.20 to 2.24) and 2.09 (95% CI = 1.57 to 2.77); and dysphagia 4.32 (95% CI = 2.46 to 7.58) and 5.91 (95% CI = 3.56 to 9.82). Sensitivity was lower for: anaemia 0.12 [95% Cl = 0.08 to 0.19] with specificity 0.97 [95% Cl = 0.94 to 0.99]; nausea/vomiting/bloating 0.17 [95% Cl = 0.05 to 0.46] and 0.84 [95% Cl = 0.60 to 0.94] respectively; reflux 0.23 [95% Cl = 0.10 to 0.46] and 0.70 [95% Cl = 0.59 to 0.80]; weight loss 0.25 [95% Cl = 0.12 to 0.43] and 0.96 [95% Cl = 0.88 to 0.98]. [corrected]. Corresponding LR+ were: anaemia 4.32 (95% CI = 2.64 to 7.08); nausea/vomiting/bloating 1.07 (95% CI = 0.52 to 2.19); reflux 0.78 (95% CI = 0.47 to 1.78) and; weight loss 5.46 (95% CI = 3.47 to 8.60).
Dysphagia, weight loss, and anaemia show the strongest association but with relatively low sensitivity and high specificity. The findings support the value of investigation of these symptoms, but also suggest that, in a population of patients who are low risk but not no-risk, investigation is not currently recommended.
选择初级保健患者进行潜在食管癌和胃癌的检查很困难,因为症状可能代表良性疾病,而良性疾病更为常见。
系统回顾初级保健中食管癌和胃癌的呈现特征,包括开放式内镜诊所中的情况。
系统评价和荟萃分析。
检索MEDLINE®、Embase、Cochrane图书馆和CINAHL,查找有症状且在初级保健或开放式内镜诊所就诊的成年人的研究。排除无症状、筛查或复发性癌症的研究。提取数据以估计食管癌和胃癌特征的诊断性能,并在荟萃分析中进行总结。
确定了14项研究。最强的汇总敏感性和特异性估计值为:消化不良分别为0.42(95%置信区间[CI]0.29至0.56)和0.48(95%CI = 0.31至0.65);疼痛分别为0.41(95%CI = 0.24至0.62)和0.75(95%CI = 0.51至0.89);吞咽困难分别为0.32(95%CI = 0.17至0.52)和0.92(95%CI = 0.81至0.97)。汇总阳性似然比(LR+)和诊断比值比为:消化不良分别为0.79(95%CI = 0.55至1.15)和0.65(95%CI = 0.32至1.33);疼痛分别为1.64(95%CI = 1.20至2.24)和2.09(95%CI = 1.57至2.77);吞咽困难分别为4.32(95%CI = 2.46至7.58)和5.91(95%CI = 3.56至9.82)。以下情况的敏感性较低:贫血为0.12[95%Cl = 0.08至0.19],特异性为0.97[95%Cl = 0.94至0.99];恶心/呕吐/腹胀分别为0.17[95%Cl = 0.05至0.46]和0.84[95%Cl = 0.60至0.94];反流分别为0.23[95%Cl = 0.10至0.46]和0.70[95%Cl = 0.59至0.80];体重减轻分别为0.25[95%Cl = 0.12至0.43]和0.96[95%Cl = 0.88至0.98]。[已校正]。相应的LR+为:贫血4.32(95%CI = 2.64至7.08);恶心/呕吐/腹胀1.07(95%CI = 0.52至2.19);反流0.78(95%CI = 0.47至1.78);体重减轻5.46(95%CI = 3.47至8.60)。
吞咽困难、体重减轻和贫血显示出最强的关联,但敏感性相对较低且特异性较高。这些发现支持对这些症状进行检查的价值,但也表明,在低风险但并非无风险的患者群体中,目前不建议进行检查。